Thermodynamically stable form of bay 43-9006 tosylate

Details for Australian Patent Application No. 2005289100 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Lenz, Jana; Grunenberg, Alfons

Agent Davies Collison Cave

Pub. Number AU-B-2005289100

PCT Pub. Number WO2006/034797

Priority 04023130.0 29.09.04 EP

Filing date 20 September 2005

Wipo publication date 6 April 2006

Acceptance publication date 3 November 2011

International Classifications

C07D 213/81 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/034797 Priority application(s): WO2006/034797

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft

3 November 2011 Application Accepted

  Published as AU-B-2005289100

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005289105-Process for the production of Ge by reduction of GeCI4, with liquid metal

2005289099-Process for the preparation of 4-{4-[({[4-chloro-3- (trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}- N-methylpyridine-2-carboxamide